Cargando…
Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normali...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261848/ https://www.ncbi.nlm.nih.gov/pubmed/34218714 http://dx.doi.org/10.1177/23247096211029750 |
_version_ | 1783719081881370624 |
---|---|
author | Menon, Lakshmi P. Rahman, Wedad |
author_facet | Menon, Lakshmi P. Rahman, Wedad |
author_sort | Menon, Lakshmi P. |
collection | PubMed |
description | Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normalization of the prolactin level. Priapism is a rare side effect of dopamine agonists that warrants discontinuation of therapy. Patients should be educated about this potential side effect at the time of prescribing the medication. |
format | Online Article Text |
id | pubmed-8261848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-82618482021-07-19 Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma Menon, Lakshmi P. Rahman, Wedad J Investig Med High Impact Case Rep Case Report Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normalization of the prolactin level. Priapism is a rare side effect of dopamine agonists that warrants discontinuation of therapy. Patients should be educated about this potential side effect at the time of prescribing the medication. SAGE Publications 2021-07-05 /pmc/articles/PMC8261848/ /pubmed/34218714 http://dx.doi.org/10.1177/23247096211029750 Text en © 2021 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Menon, Lakshmi P. Rahman, Wedad Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma |
title | Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma |
title_full | Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma |
title_fullStr | Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma |
title_full_unstemmed | Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma |
title_short | Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma |
title_sort | recurrent priapism from cabergoline and bromocriptine in a
hypogonadal man with prolactinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261848/ https://www.ncbi.nlm.nih.gov/pubmed/34218714 http://dx.doi.org/10.1177/23247096211029750 |
work_keys_str_mv | AT menonlakshmip recurrentpriapismfromcabergolineandbromocriptineinahypogonadalmanwithprolactinoma AT rahmanwedad recurrentpriapismfromcabergolineandbromocriptineinahypogonadalmanwithprolactinoma |